辛勤的白枫
Lv1
40 积分
2024-08-14 加入
-
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
4天前
已完结
-
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications
5天前
已完结
-
Inflammation in Obesity-Related HFpEF
5天前
已完结
-
Heart failure with preserved ejection fraction: everything the clinician needs to know
5天前
已完结
-
Type 2 diabetes mellitus pharmacological remission with dapagliflozin plus oral semaglutide
5天前
已完结
-
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
5天前
已关闭
-
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
5天前
已完结
-
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
6天前
已完结
-
Inflammation in Obesity-Related HFpEF
6天前
已完结
-
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure
6天前
已完结